NGF is a potential therapeutic agent for various ocular surface diseases, particularly those involving epithelial regeneration (e.g., NK), inflammation (e.g., allergic conjunctivitis and immune keratitis), infection (e.g., HSV keratitis), and post-surgical corneal wound healing. This evidence concerns the gene NGF and atopic conjunctivitis.